These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol. Sun L; Zhao R; Zhang L; Zhang W; He G; Yang S; Song J; Du G Biochem Pharmacol; 2016 Mar; 103():40-52. PubMed ID: 26807478 [TBL] [Abstract][Full Text] [Related]
26. Small nucleolar RNA host gene 18 controls vascular smooth muscle cell contractile phenotype and neointimal hyperplasia. Niu K; Zhang C; Yang M; Maguire EM; Shi Z; Sun S; Wu J; Liu C; An W; Wang X; Gao S; Ge S; Xiao Q Cardiovasc Res; 2024 May; 120(7):796-810. PubMed ID: 38498586 [TBL] [Abstract][Full Text] [Related]
27. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway. Huang C; Zhang W; Zhu Y Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560 [TBL] [Abstract][Full Text] [Related]
28. Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway. He Y; Zou P; Lu Y; Jia D; Li X; Yang H; Tang L; Zhu Z; Tu T; Tai S; Xiao Y; Chen M; Lu L; Zhou S J Mol Cell Cardiol; 2020 Feb; 139():1-13. PubMed ID: 31958462 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-15b/16 Attenuates Vascular Neointima Formation by Promoting the Contractile Phenotype of Vascular Smooth Muscle Through Targeting YAP. Xu F; Ahmed AS; Kang X; Hu G; Liu F; Zhang W; Zhou J Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2145-52. PubMed ID: 26293467 [TBL] [Abstract][Full Text] [Related]
30. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype. van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726 [TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins. Begum N; Hockman S; Manganiello VC J Biol Chem; 2011 Jul; 286(29):26238-49. PubMed ID: 21632535 [TBL] [Abstract][Full Text] [Related]
32. NR6A1 couples with cAMP response element binding protein and regulates vascular smooth muscle cell migration. Wang Y; Zhang Y; Dai X; Liu Z; Yin P; Wang N; Zhang P Int J Biochem Cell Biol; 2015 Dec; 69():225-32. PubMed ID: 26546462 [TBL] [Abstract][Full Text] [Related]
33. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway. Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081 [TBL] [Abstract][Full Text] [Related]
34. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation. Nurminskaya M; Beazley KE; Smith EP; Belkin AM J Vasc Res; 2014; 51(6):418-28. PubMed ID: 25612735 [TBL] [Abstract][Full Text] [Related]
36. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration. Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326 [TBL] [Abstract][Full Text] [Related]
37. Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia. Nakanishi K; Saito Y; Azuma N; Sasajima T J Vasc Surg; 2013 Jan; 57(1):182-93, 193.e1-10. PubMed ID: 23127979 [TBL] [Abstract][Full Text] [Related]
38. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling. Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409 [TBL] [Abstract][Full Text] [Related]
39. NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells. Sun X; Li S; Gan X; Chen K; Yang D; Yang Y Aging (Albany NY); 2020 May; 12(10):9726-9744. PubMed ID: 32422606 [TBL] [Abstract][Full Text] [Related]
40. Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension. Zhang L; Xie P; Wang J; Yang Q; Fang C; Zhou S; Li J J Biol Chem; 2010 Apr; 285(18):13666-77. PubMed ID: 20212046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]